U.S. markets open in 8 hours 53 minutes

Sarepta Therapeutics: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Sarepta Therapeutics Inc. (SRPT) on Wednesday reported a loss of $235.7 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of $3.16 per share.

The biopharmaceutical company posted revenue of $100.1 million in the period.

For the year, the company reported that its loss widened to $715.1 million, or $9.71 per share. Revenue was reported as $380.8 million.

Sarepta Therapeutics shares have declined 12% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $113.63, a fall of 19% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT